#gsk — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #gsk, aggregated by home.social.
-
GSK (LSE:GSK), What Is Behind The Latest Attention?
GSK (LSE:GSK) is back in focus after presenting positive phase II data for its mRNA seasonal flu vaccine…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/118415/ -
https://www.europesays.com/britain/118415/ GSK (LSE:GSK), What Is Behind The Latest Attention? #GSK
-
https://www.europesays.com/britain/?p=118119 Mobile livescore – Flashscore.mobi football scores #GSK
-
GSK advances mRNA flu vaccine to phase 3 after positive results
(Alliance News) – GSK PLC on Tuesday said a phase 2 probe of its mRNA flu vaccine candidate…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117985/ -
https://www.europesays.com/britain/117985/ GSK advances mRNA flu vaccine to phase 3 after positive results #GSK
-
Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830
(Alliance News) – Hutchmed China PLC on Thursday announced that its subsidiary, Hutchmed Ltd, has entered into an…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117974/ -
https://www.europesays.com/britain/117974/ Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830 #GSK
-
Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?
GSK plc (NYSE:GSK) has reached two important regulatory milestones involving treatments for chronic hepatitis B and rectal cancer.…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #Jemperli #NYSE
https://www.europesays.com/britain/117964/ -
https://www.europesays.com/britain/117964/ Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity? #GSK #GSKPlc #Jemperli #NYSE
-
Hesham A. Abdullah Announces a New Oncology Partnership Between GSK and HUTCHMED
Hesham A. Abdullah/LinkedIn Hesham A. Abdullah, Senior Vice President of Global Head Oncology, Research and Development at GSK…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117866/ -
https://www.europesays.com/britain/117866/ Hesham A. Abdullah Announces a New Oncology Partnership Between GSK and HUTCHMED #GSK
-
HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma
Shanghai: GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED (China) $110 million…
#EuropeSays #Britain #Europe #EU #GSK #experimentalsolidtumourdrug #GlaxoSmithKline #HMPL-A830 #HUTCHMEDlicensingdeal #solidtumours
https://www.europesays.com/britain/117654/ -
https://www.europesays.com/britain/117654/ HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma #ExperimentalSolidTumourDrug #GlaxoSmithKline #GSK #HMPLA830 #HUTCHMEDLicensingDeal #SolidTumours
-
GSK advances mRNA flu shot after Phase II success
Drugmaker GSK said on Tuesday that it will move its mRNA seasonal flu vaccine candidate into Phase III…
#EuropeSays #Britain #Europe #EU #GSK #advances #after #Category:All #Category:CompanyNews #Category:MarketPulse #Category:MarketReport #Category:NewsandAnnouncements #Category:Sectorial:HealthTechnology #mRNA #Phase #shot #success
https://www.europesays.com/britain/117636/ -
Hutchmed, GSK Ink $1.3B Cancer Drug Deal
Hutchmed Limited has entered into an exclusive development and license agreement with a subsidiary of GSK plc, giving…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117616/ -
https://www.europesays.com/britain/117616/ Hutchmed, GSK Ink $1.3B Cancer Drug Deal #GSK
-
Is GSK (LSE:GSK) Still Reasonable, Or Is The Value Already Priced In?
GSK stock has delivered a strong 54.4% gain over the past 5 years, yet the current checks still…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117597/ -
https://www.europesays.com/britain/117597/ Is GSK (LSE:GSK) Still Reasonable, Or Is The Value Already Priced In? #GSK
-
GSK (LSE:GSK) Wins First Global Approval For Chronic Hepatitis B Functional Cure
GSK (LSE:GSK) has received the world’s first regulatory approval for Hibsago (bepirovirsen) as a functional cure for chronic…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117584/ -
https://www.europesays.com/britain/117584/ GSK (LSE:GSK) Wins First Global Approval For Chronic Hepatitis B Functional Cure #GSK
-
China’s Hutchmed inks $1.3 B deal with GSK for KRAS-EGFR-antibody conjugate cancer therapy
China’s Hutchmed inks $1.3 B deal with GSK for KRAS-EGFR-antibody conjugate cancer therapy September 4, 2026 | Friday…
#EuropeSays #Britain #Europe #EU #GSK #Cancer #China #EGFR #Hutchmed #KRAS
https://www.europesays.com/britain/117573/ -
HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug
Sept 3 (Reuters) – GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED…
#EuropeSays #Britain #Europe #EU #GSK #Markets
https://www.europesays.com/britain/117557/ -
https://www.europesays.com/britain/117557/ HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug #GSK #Markets
-
GSK to Advance mRNA Influenza Vaccine Into Phase III Development
GSK plc GSK announced that it plans to advance the mRNA-based seasonal influenza (flu) vaccine candidate into late-stage development.…
#EuropeSays #Britain #Europe #EU #GSK #AnikaTherapeutics #AnikaTherapeuticsANIK #GSKPLCSponsoredADR #PLC) #Repligen #RepligenRGEN #Zacks #ZacksInvestmentResearch
https://www.europesays.com/britain/117543/ -
https://www.europesays.com/britain/117543/ GSK to Advance mRNA Influenza Vaccine Into Phase III Development #AnikaTherapeutics #AnikaTherapeuticsANIK #GSK #GSKPLCSponsoredADR #PLC) #Repligen #RepligenRGEN #Zacks #ZacksInvestmentResearch
-
GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says
GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says Proactive uses images sourced from Shutterstock GSK…
#EuropeSays #Britain #Europe #EU #GSK #deutschebank #Moderna
https://www.europesays.com/britain/117528/ -
https://www.europesays.com/britain/117528/ GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says #DeutscheBank #GSK #Moderna
-
Is GSK (LSE:GSK) Losing The Room As Vaccine Demand Questions Resurface?
Highlights GSK featured among the sharpest decliners on London’s leading benchmark Vaccine demand patterns remain the most closely…
#EuropeSays #Britain #Europe #EU #GSK #IsGSK(LSE:GSK)LosingTheRoomAsVaccineDemandQuestionsResurface?
https://www.europesays.com/britain/117512/ -
Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK?
Moderna MRNA recently secured FDA approval for mFlusiva, the first mRNA-based seasonal flu vaccine. The decision is a…
#EuropeSays #Britain #Europe #EU #GSK #futures #indexmarketquote #indexmarketquotes #indexmarketsymbol #indexmarketsymbols #indices #ModernaInc #mRNA #TheGlobeandMail
https://www.europesays.com/britain/116951/ -
https://www.europesays.com/britain/116951/ Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK? #futures #GSK #IndexMarketQuote #IndexMarketQuotes #IndexMarketSymbol #IndexMarketSymbols #indices #ModernaInc #mRNA #TheGlobeAndMail
-
https://www.europesays.com/britain/116875/ Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK? #FDA #GSK #GSKPlcGSK #Inc #mFlusiva #Moderna #ModernaMRNA #mRNA #ZacksInvestmentResearch #ZacksInvestmentResearchModerna
-
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
GSK continues to look eastward for novel assets, this time partnering with Hong Kong-based HUTCHMED to develop an…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/116755/ -
5 neuro data readouts to watch in the second half of 2024 — GSK moves to new HQ in return to central London — AbbVie led the way in paying doctors to pitch its drugs last year —http://bit.ly/w28kSd #clinicaltrials #neurology #gsk #london #abbvie #physicians #physicianpayments #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
GSK to sell remaining stake in Haleon, looks to raise $1.52B—US unveils proposal to ease restrictions on marijuana —FDA approves Amgen drug for small cell lung cancer --http://bit.ly/w28kSd #gsk #haleon #consumerhealth #pot #marijuana #medicalmarijuana #fda #amgen #smallcelllungcancer #lungcancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
#Drugmakers Are Set to Pay #23andMe Millions to Access Consumer #DNA
#GSK will pay the DNA testing company $20 million for non-exclusive access to #genetic data. https://www.bloomberg.com/news/articles/2023-10-30/23andme-will-give-gsk-access-to-consumer-dna-data?leadSource=reddit_wall